Lucid Diagnostics Inc (NASDAQ: LUCD) is -29.08% lower on its value in year-to-date trading and has touched a low of $0.63 and a high of $1.58 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LUCD stock was last observed hovering at around $0.96 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $1.00, the stock is 2.77% and 13.82% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.93 million and changing 4.62% at the moment leaves the stock 9.55% off its SMA200. LUCD registered -23.08% loss for a year compared to 6-month loss of 9.29%. The firm has a 50-day simple moving average (SMA 50) of $0.87526 and a 200-day simple moving average (SMA200) of $0.914415.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 16.28% gain in the last 1 month and extending the period to 3 months gives it a 18.06%, and is -4.76% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.40% over the week and 6.74% over the month.
Lucid Diagnostics Inc (LUCD) has around 70 employees, a market worth around $59.34M and $4.19M in sales. Profit margin for the company is -1248.84%. Distance from 52-week low is 58.70% and -36.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-626.59%).
The EPS is expected to grow by 84.66% this year
34.0 institutions hold shares in Lucid Diagnostics Inc (LUCD), with institutional investors hold 10.28% of the company’s shares. The shares outstanding are 42.33M, and float is at 19.02M with Short Float at 2.22%. Institutions hold 4.21% of the Float.
The top institutional shareholder in the company is LUMINUS MANAGEMENT LLC with over 0.73 million shares valued at $0.6 million. The investor’s holdings represent 1.6124 of the LUCD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.56 million shares valued at $0.46 million to account for 1.2461 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.2 million shares representing 0.454 and valued at over $0.17 million, while NANTAHALA CAPITAL MANAGEMENT, LLC holds 0.2807 of the shares totaling 0.13 million with a market value of $0.1 million.
